CELLULAR BIOMEDICINE GROUP I's ticker is CBMG and the CUSIP is 15117P102. A total of 40 filers reported holding CELLULAR BIOMEDICINE GROUP I in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $5,924,000 | +268.9% | 322,242 | +268.2% | 0.00% | – |
| Q3 2020 | $1,606,000 | +430.0% | 87,524 | +424.1% | 0.00% | – |
| Q3 2018 | $303,000 | -68.6% | 16,700 | -69.6% | 0.00% | – |
| Q1 2018 | $964,000 | +201.2% | 54,928 | +50.2% | 0.00% | – |
| Q2 2017 | $320,000 | -0.6% | 36,573 | +48.8% | 0.00% | – |
| Q4 2016 | $322,000 | -51.9% | 24,584 | +15.6% | 0.00% | – |
| Q1 2015 | $669,000 | – | 21,270 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|